Prasad S. Adusumilli

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

Leonid Cherkassky, Aurore Morello, Jonathan Villena‐Vargas et al. · Journal of Clinical Investigation · 2016 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas

Kyuichi Kadota, Jun‐ichi Nitadori, Camelia S. Sima et al. · Journal of Thoracic Oncology · 2015 · 674 citations · Full text

Medicine, Oncology, Surgery +17

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

Prasad S. Adusumilli, Leonid Cherkassky, Jonathan Villena‐Vargas et al. · Science Translational Medicine · 2014 · 567 citations

Life Sciences, Immunology, Oncology +13

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière et al. · Cancer Discovery · 2021 · 560 citations · Full text

Medicine, Oncology, Pharmacology +17

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Cristina Valero, Mark Lee, Douglas R. Hoen et al. · Nature Communications · 2021 · 456 citations · Full text

Life Sciences, Immunology, Oncology +17